These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20383463)

  • 1. MG132, a proteasome inhibitor, attenuates pressure-overload-induced cardiac hypertrophy in rats by modulation of mitogen-activated protein kinase signals.
    Chen B; Ma Y; Meng R; Xiong Z; Zhang C; Chen G; Zhang A; Dong Y
    Acta Biochim Biophys Sin (Shanghai); 2010 Apr; 42(4):253-8. PubMed ID: 20383463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteasome inhibition attenuates heart failure during the late stages of pressure overload through alterations in collagen expression.
    Ma Y; Chen Y; Yang Y; Chen B; Liu D; Xiong Z; Zhang C; Dong Y
    Biochem Pharmacol; 2013 Jan; 85(2):223-33. PubMed ID: 23142711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MG132 treatment attenuates cardiac remodeling and dysfunction following aortic banding in rats via the NF-κB/TGFβ1 pathway.
    Ma Y; Chen B; Liu D; Yang Y; Xiong Z; Zeng J; Dong Y
    Biochem Pharmacol; 2011 May; 81(10):1228-36. PubMed ID: 21420391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.
    Li HL; Wang AB; Huang Y; Liu DP; Wei C; Williams GM; Zhang CN; Liu G; Liu YQ; Hao DL; Hui RT; Lin M; Liang CC
    Free Radic Biol Med; 2005 Jan; 38(2):243-57. PubMed ID: 15607907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of 17-methoxyl-7-hydroxy-benzene-furanchalcone on the pressure overload-induced progression of cardiac hypertrophy to cardiac failure.
    Huang J; Tang X; Liang X; Wen Q; Zhang S; Xuan F; Jian J; Lin X; Huang R
    PLoS One; 2014; 9(3):e91834. PubMed ID: 24622486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
    Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L
    Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
    See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
    J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteasome inhibitors attenuated cholesterol-induced cardiac hypertrophy in H9c2 cells.
    Lee H; Park J; Kim EE; Yoo YS; Song EJ
    BMB Rep; 2016 May; 49(5):270-5. PubMed ID: 26592933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteasome inhibition-induced p38 MAPK/ERK signaling regulates autophagy and apoptosis through the dual phosphorylation of glycogen synthase kinase 3β.
    Choi CH; Lee BH; Ahn SG; Oh SH
    Biochem Biophys Res Commun; 2012 Feb; 418(4):759-64. PubMed ID: 22310719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy.
    Li HL; Yin R; Chen D; Liu D; Wang D; Yang Q; Dong YG
    J Cell Biochem; 2007 Apr; 100(5):1086-99. PubMed ID: 17266062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitogen-activated protein kinase inhibitors differently affect the growth inhibition and death of a proteasome inhibitor, MG132-treated human pulmonary fibroblast cells.
    Park WH
    Hum Exp Toxicol; 2011 Dec; 30(12):1945-54. PubMed ID: 21421692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of TRADD attenuates pressure overload-induced cardiac hypertrophy through regulating TAK1/P38 MAPK signalling in mice.
    Wu L; Cao Z; Ji L; Mei L; Jin Q; Zeng J; Lin J; Chu M; Li L; Yang X
    Biochem Biophys Res Commun; 2017 Feb; 483(2):810-815. PubMed ID: 28013046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMPK activation enhances PPARα activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway.
    Meng R; Pei Z; Zhang A; Zhou Y; Cai X; Chen B; Liu G; Mai W; Wei J; Dong Y
    Arch Biochem Biophys; 2011 Jul; 511(1-2):1-7. PubMed ID: 21530483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-specificity phosphatase 14 protects the heart from aortic banding-induced cardiac hypertrophy and dysfunction through inactivation of TAK1-P38MAPK/-JNK1/2 signaling pathway.
    Li CY; Zhou Q; Yang LC; Chen YH; Hou JW; Guo K; Wang YP; Li YG
    Basic Res Cardiol; 2016 Mar; 111(2):19. PubMed ID: 26891723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosuvastatin prevents pressure overload‑induced myocardial hypertrophy via inactivation of the Akt, ERK1/2 and GATA4 signaling pathways in rats.
    Xu X; Zhang L; Liang J
    Mol Med Rep; 2013 Aug; 8(2):385-92. PubMed ID: 23799547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of cardiomyocyte hypertrophy by inhibition of the ubiquitin-proteasome system.
    Meiners S; Dreger H; Fechner M; Bieler S; Rother W; Günther C; Baumann G; Stangl V; Stangl K
    Hypertension; 2008 Feb; 51(2):302-8. PubMed ID: 18086945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breviscapine protects against cardiac hypertrophy through blocking PKC-alpha-dependent signaling.
    Yan L; Huang H; Tang QZ; Zhu LH; Wang L; Liu C; Bian ZY; Li H
    J Cell Biochem; 2010 Apr; 109(6):1158-71. PubMed ID: 20127712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quercetin Prevents In Vivo and In Vitro Myocardial Hypertrophy Through the Proteasome-GSK-3 Pathway.
    Chen K; Rekep M; Wei W; Wu Q; Xue Q; Li S; Tian J; Yi Q; Zhang G; Zhang G; Xiao Q; Luo J; Liu Y
    Cardiovasc Drugs Ther; 2018 Feb; 32(1):5-21. PubMed ID: 29435775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Jak2 phosphorylation attenuates pressure overload cardiac hypertrophy.
    Beckles DL; Mascareno E; Siddiqui MA
    Vascul Pharmacol; 2006 Dec; 45(6):350-7. PubMed ID: 16822720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S; Long CL; Wang RH; Wang H
    Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.